Corrine Ying Xuan Chua

Author

Houston Methodist ORCID

Also Known As

C Y Chua, C.Y. Chua, Corrine Chua, Corrine Y. X. Chua, Corrine Ying Xuan Chua, Corrine Yingxuan Chua, Ying Xuan Chua

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Houston Methodist Methodist Hospital The University of Texas MD Anderson Cancer Center Tecnológico de Monterrey Polytechnic University of Turin

About

Corrine Ying Xuan Chua is an author at Houston Methodist specializing in medicine, biomedical engineering, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	781
2	Biomedical Engineering	12	12	579
3	Engineering	8	8	364
4	Health Sciences	2	2	93
5	Applied Physiology	1	1	14

Corrine Ying Xuan Chua

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network Kristen M. Holmes, Matti Annala, Corrine Ying Xuan Chua, Proceedings of the National Academy of Sciences Nf-κb NetworkIntegrin-linked KinaseIntegrin β1Significant IntegrinHigh-grade Gliomas	2012	112
IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma Song Gao, Yan Sun, Xuebin Zhang, Cancer Research	2016	106
Carbon fiber reinforced polymers for implantable medical devices Corrine Ying Xuan Chua, Hsuan‐Chen Liu, Nicola Di Trani, Biomaterials Fiber ReinforcementFibre-reinforced PlasticCarbon FiberBiomedical EngineeringImplantable Device	2021	101
IGFBP2 potentiates nuclear EGFR–STAT3 signaling Corrine Ying Xuan Chua, Yi Liu, K Granberg, Oncogene Transcriptional RegulationSignal TransductionSignaling PathwayReceptor Tyrosine KinaseNuclear Egfr–stat3 Signaling	2015	92
Emerging Technologies for Local Cancer Treatment Corrine Ying Xuan Chua, Jeremy Ho, Sandra Demaria, Advanced Therapeutics Cancer ManagementBiomedical EngineeringSite-specific DeliveryNanomedicineOncology	2020	79
Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis Corrine Ying Xuan Chua, Priya Jain, Andrea Ballerini, Journal of Controlled Release NanomedicineEngineeringBiomedical EngineeringTenofovir DiphosphateBiomems	2018	78
Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1 Hsuan‐Chen Liu, Dixita Viswanath, Federica Pesaresi, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineSustained Intratumoral DeliveryImmunologyPharmacology	2020	68
Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer Corrine Ying Xuan Chua, Priya Jain, Antonia Susnjar, Journal of Controlled Release Nanofluidic Drug-eluting SeedNanomedicineBreast OncologyEngineeringImmunology	2018	60
Transcutaneously refillable, 3D-printed biopolymeric encapsulation system for the transplantation of endocrine cells Marco Farina, Corrine Ying Xuan Chua, Andrea Ballerini, Biomaterials Tissue EngineeringRegenerative MedicineEndocrine CellsCell-based Drug DeliveryEngineering	2018	59
2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis Fernanda P. Pons‐Faudoa, Antons Sizovs, Nicola Di Trani, Journal of Controlled Release NanomedicineEngineeringMedicineAntiviral Drug DevelopmentAntiviral Therapy	2019	55

Page 1